BEAM logo

Beam Therapeutics Inc. (BEAM)

Profile

Full Name

Beam Therapeutics Inc.

Ticker

NASDAQ: BEAM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 6, 2020

Indexes

Not included

Website

https://beamtx.com

Employees

393

Key Details

Price

$18.83(-4.46%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$63.52M(-83.18% YoY)

Annual EPS

-$4.58(-166.28% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $18.83
    BEAM price is $18.83

    30-Day Relative Volume

    1.15
    BEAM 30-day relative volume is 1.15

    Price Performance

    Price Most recent change

    -4.46%
    BEAM price was down -4.46% on Aug 1, 2025

    Price YTD change

    -24.07%
    BEAM price is down -24.07% since January 1st

    Price 1-year change

    -37.88%
    BEAM price is down -37.88% year-on-year

    Price 3-year change

    -68%
    BEAM price is down -68% over the past 3 years

    Price Range

    Price All-time high

    $138.52
    BEAM price is currently -86.41% below its historical high of $138.52

    Price 3-year low

    $13.53
    BEAM price is currently +39.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.89B
    BEAM market capitalization is $1.89 billion

    Market cap 3-year change

    -54.23%
    BEAM market capitalization is down -54.23% over the past 3 years

    Market cap All-time high

    $8.61B
    BEAM market capitalization is currently -78.01% below its historical high of $8.61 billion

    Market cap sector rank

    81.67%
    BEAM market capitalization is higher than 81.67% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +22.01%
    BEAM shares outstanding is up +22.01% year-on-year

    Shares Outstanding 3-Year Change

    +43.02%
    BEAM shares outstanding is up +43.02% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.76
    BEAM beta is 1.76

    200-day SMA

    $22.72
    BEAM price is currently -17.12% below its 200-day simple moving average

    50-day SMA

    $18.62
    BEAM price is currently +1.15% above its 50-day simple moving average

    RSI

    43.72
    BEAM 14-day relative strength index is 43.72

    Volume

    1.15
    BEAM 30-day relative volume is 1.15

    ATR

    $1.23
    BEAM average true range is $1.23

    10-day Historical Volatility

    56.11%
    BEAM 10-day historical volatility is 56.11%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $63.52M
    BEAM annual revenue is $63.52 million

    Revenue Analysts estimate

    $55.40M
    BEAM annual revenue is currently +14.65% higher than the consensus analysts' forecast

    Revenue 1-year change

    -83.18%
    BEAM annual revenue is down -83.18% year-on-year

    Revenue Sector rank

    50%
    BEAM annual revenue is higher than 50% of companies in Healthcare sector

    EPS

    EPS

    -$4.58
    BEAM annual earnings per share is -$4.58

    EPS Analysts estimate

    -$4.50
    BEAM annual earnings per share is currently +1.74% higher than the consensus analysts' forecast

    EPS 1-year change

    -166.28%
    BEAM annual earnings per share is down -166.28% year-on-year

    EPS Sector rank

    22.05%
    BEAM annual earnings per share is higher than 22.05% of companies in Healthcare sector

    Profit

    Gross profit

    -
    BEAM annual gross profit value is unknown

    Gross margin

    -
    BEAM annual gross profit margin value is unknown

    Operating profit

    -$415.57M
    BEAM annual operating income is -$415.57 million

    Operating margin

    -654.25%
    BEAM annual operating profit margin is -654.25%

    Net income

    -$376.74M
    BEAM annual net profit is -$376.74 million

    Net margin

    -593.13%
    BEAM annual net profit margin is -593.13%

    Expenses

    Total expenses

    $479.09M
    BEAM annual total expenses is $479.09 million

    Operating expenses

    $479.09M
    BEAM annual total operating expenses is $479.09 million

    Cost of goods sold

    -
    BEAM annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $111.53M
    BEAM annual SGA is $111.53 million

    Depreciation and amortization

    $31.59M
    BEAM annual depreciation & amortization is $31.59 million

    Interest expense

    -
    BEAM annual interest expense value is unknown

    Income tax

    $39.00K
    BEAM annual income tax is $39.00 thousand

    EBIT & EBITDA

    EBIT

    -$415.57M
    BEAM annual earnings before interest & taxes is -$415.57 million

    EBITDA

    -$383.98M
    BEAM annual EBITDA is -$383.98 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.10B
    BEAM annual total assets is $1.10 billion

    Non current assets

    $225.68M
    BEAM annual long term assets is $225.68 million

    Current assets

    $878.15M
    BEAM annual total current assets is $878.15 million

    Cash and cash equivalents

    $281.97M
    BEAM annual cash & cash equivalents is $281.97 million

    Accounts receivable

    -
    BEAM annual accounts receivable value is unknown

    Inventory

    -
    BEAM annual inventory value is unknown

    Liabilities

    Total liabilities

    $370.28M
    BEAM annual total liabilities is $370.28 million

    Long term liabilities

    $188.21M
    BEAM annual total long term liabilities is $188.21 million

    Current liabilities

    $182.07M
    BEAM annual total current liabilities is $182.07 million

    Accounts payable

    $3.87M
    BEAM annual accounts payable is $3.87 million

    Debt

    Total debt

    $161.43M
    BEAM annual total debt is $161.43 million

    Total debt 1-year change

    -6.52%
    BEAM annual total debt is down -6.52% year-on-year

    Long term debt

    $147.96M
    BEAM annual long term debt is $147.96 million

    Short term debt

    $13.47M
    BEAM annual short term debt is $13.47 million

    Equity & Capital

    Shareholders equity

    $733.54M
    BEAM annual stockholders equity is $733.54 million

    Book value

    $733.54M
    BEAM annual book value is $733.54 million

    Retained earnings

    -$1.57B
    BEAM annual retained earnings is -$1.57 billion

    Working capital

    $696.08M
    BEAM annual working capital is $696.08 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$347.25M
    BEAM annual cash flow from operations is -$347.25 million

    Cash from operations 1-year change

    -132.75%
    BEAM annual cash flow from operations is down -132.75% year-on-year

    Cash from investing

    $185.01M
    BEAM annual cash flow from investing activities is $185.01 million

    Cash from investing 1-year change

    +157.53%
    BEAM annual cash flow from investing activities is up +157.53% year-on-year

    Cash from financing

    $7.74M
    BEAM annual cash flow from financing activities is $7.74 million

    Cash from financing 1-year change

    -97.2%
    BEAM annual cash flow from financing activities is down -97.2% year-on-year

    CAPEX

    CAPEX

    $8.95M
    BEAM annual capital expenditures is $8.95 million

    CAPEX 1-year change

    -73.48%
    BEAM annual capital expenditures is down -73.48% year-on-year

    Free Cash Flow

    Free cash flow

    -$356.19M
    BEAM annual free cash flow is -$356.19 million

    Free cash flow 1-year change

    -94.72%
    BEAM annual free cash flow is down -94.72% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BEAM annual gross profit margin value is unknown

    Operating margin

    -654.25%
    BEAM annual operating profit margin is -654.25%

    Net margin

    -593.13%
    BEAM annual net profit margin is -593.13%

    ROA & ROE

    ROA

    -29.39%
    BEAM annual return on assets is -29.39%

    ROE

    -43.94%
    BEAM annual return on equity is -43.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BEAM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BEAM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.69
    BEAM price to book ratio is 1.69

    PB ratio Sector rank

    51.12%
    BEAM price to book ratio is higher than 51.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    29.78
    BEAM price to sales ratio is 29.78

    PS ratio Sector rank

    88.13%
    BEAM price to sales ratio is higher than 88.13% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.52B
    BEAM enterprise value is $1.52 billion

    Enterprise value Sector rank

    78.24%
    BEAM enterprise value is higher than 78.24% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.82
    BEAM EV/EBITDA is -3.82

    EV/EBITDA Sector rank

    27.67%
    BEAM EV/EBITDA is higher than 27.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.82
    BEAM annual current ratio is 4.82

    Quick ratio

    -
    BEAM annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    BEAM annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    BEAM annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BEAM piotroski f-score value is unknown

    Altman Z-Score

    0.65
    BEAM altman z-score is 0.65

    Analyst ratings

    Recent major analysts updates

    May 7, 25 Wells Fargo
    Overweight
    May 7, 25 Guggenheim
    Buy
    May 7, 25 Barclays
    Equal-Weight
    Apr 7, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 B of A Securities
    Buy
    Mar 12, 25 Cantor Fitzgerald
    Overweight
    Mar 10, 25 Scotiabank
    Sector Outperform
    Mar 10, 25 Jones Trading
    Buy
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Mar 3, 25 Scotiabank
    Sector Perform

    Institutional Ownership

    Screeners with BEAM included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Beam Therapeutics Inc.?
    • Does Beam Therapeutics Inc. pay dividends?
    • What sector is Beam Therapeutics Inc. in?
    • What industry is Beam Therapeutics Inc. in?
    • What country is Beam Therapeutics Inc. based in?
    • When did Beam Therapeutics Inc. go public?
    • Is Beam Therapeutics Inc. in the S&P 500?
    • Is Beam Therapeutics Inc. in the NASDAQ 100?
    • Is Beam Therapeutics Inc. in the Dow Jones?
    • When was Beam Therapeutics Inc.'s last earnings report?
    • When does Beam Therapeutics Inc. report earnings?

    What is the ticker symbol for Beam Therapeutics Inc.?

    The ticker symbol for Beam Therapeutics Inc. is NASDAQ:BEAM

    Does Beam Therapeutics Inc. pay dividends?

    No, Beam Therapeutics Inc. does not pay dividends

    What sector is Beam Therapeutics Inc. in?

    Beam Therapeutics Inc. is in the Healthcare sector

    What industry is Beam Therapeutics Inc. in?

    Beam Therapeutics Inc. is in the Biotechnology industry

    What country is Beam Therapeutics Inc. based in?

    Beam Therapeutics Inc. is headquartered in United States

    When did Beam Therapeutics Inc. go public?

    Beam Therapeutics Inc.'s initial public offering (IPO) was on February 6, 2020

    Is Beam Therapeutics Inc. in the S&P 500?

    No, Beam Therapeutics Inc. is not included in the S&P 500 index

    Is Beam Therapeutics Inc. in the NASDAQ 100?

    No, Beam Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Beam Therapeutics Inc. in the Dow Jones?

    No, Beam Therapeutics Inc. is not included in the Dow Jones index

    When was Beam Therapeutics Inc.'s last earnings report?

    Beam Therapeutics Inc.'s most recent earnings report was on May 6, 2025

    When does Beam Therapeutics Inc. report earnings?

    The next expected earnings date for Beam Therapeutics Inc. is August 6, 2025
    On this page